Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Roles of flavonoids against coronavirus infection
Maria Russo, Stefania Moccia, Carmela Spagnuolo, et al.
Chemico-Biological Interactions (2020) Vol. 328, pp. 109211-109211
Open Access | Times Cited: 301

Showing 1-25 of 301 citing articles:

Long‐COVID syndrome‐associated brain fog and chemofog: Luteolin to the rescue
Theoharis C. Theoharides, Christos Cholevas, Konstantinos S. Polyzoidis, et al.
BioFactors (2021) Vol. 47, Iss. 2, pp. 232-241
Open Access | Times Cited: 185
Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors
Sk. Abdul Amin, Suvankar Banerjee, Kalyan Ghosh, et al.
Bioorganic & Medicinal Chemistry (2020) Vol. 29, pp. 115860-115860
Open Access | Times Cited: 175
Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma
Duraisamy Kempuraj, Ramasamy Thangavel, Deepak D. Kempuraj, et al.
BioFactors (2020) Vol. 47, Iss. 2, pp. 190-197
Closed Access | Times Cited: 159
Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2)
Chaima Mouffouk, Soumia Mouffouk, Sara Mouffouk, et al.
European Journal of Pharmacology (2020) Vol. 891, pp. 173759-173759
Open Access | Times Cited: 151
Polyphenols and their potential role to fight viral diseases: An overview
María Fernanda Montenegro-Landívar, Paulina Tapia-Quirós, Xanel Vecino, et al.
The Science of The Total Environment (2021) Vol. 801, pp. 149719-149719
Open Access | Times Cited: 151
Flavonoids are promising safe therapy against COVID-19
Moza Mohamed Alzaabi, Rania Hamdy, Naglaa S. Ashmawy, et al.
Phytochemistry Reviews (2021) Vol. 21, Iss. 1, pp. 291-312
Open Access | Times Cited: 133
Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?
Theoharis C. Theoharides
Molecular Neurobiology (2022) Vol. 59, Iss. 3, pp. 1850-1861
Open Access | Times Cited: 126
Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2
Ashuai Du, Rong Zheng, Cyrollah Disoma, et al.
International Journal of Biological Macromolecules (2021) Vol. 176, pp. 1-12
Open Access | Times Cited: 106
An ethnopharmacological review on the therapeutical properties of flavonoids and their mechanisms of actions: A comprehensive review based on up to date knowledge
Doha H. Abou Baker
Toxicology Reports (2022) Vol. 9, pp. 445-469
Open Access | Times Cited: 75
Quercetin: Antiviral Significance and Possible COVID-19 Integrative Considerations
Pawan K. Agrawal, Chandan Agrawal, Gerald Blunden
Natural Product Communications (2020) Vol. 15, Iss. 12
Open Access | Times Cited: 99
Antimicrobial Activity of Bee-Collected Pollen and Beebread: State of the Art and Future Perspectives
Nikos Asoutis Didaras, Katerina Karatasou, Tilemachos G. Dimitriou, et al.
Antibiotics (2020) Vol. 9, Iss. 11, pp. 811-811
Open Access | Times Cited: 94
Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2
Vijaya Anand Arumugam, Balamuralikrishnan Balasubramanian, Mohandass Kaviya, et al.
Molecules (2021) Vol. 26, Iss. 6, pp. 1775-1775
Open Access | Times Cited: 90
Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review
Ridhima Kaul, Pradipta Paul, Sanjay Kumar, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11069-11069
Open Access | Times Cited: 76
Potential role of interferons in treating COVID-19 patients
Mohadeseh Haji Abdolvahab, Shima Moradi‐Kalbolandi, Mohammad Zarei, et al.
International Immunopharmacology (2020) Vol. 90, pp. 107171-107171
Open Access | Times Cited: 71
Antiviral Activity of Vitis vinifera Leaf Extract against SARS-CoV-2 and HSV-1
Carla Zannella, Rosa Giugliano, Annalisa Chianese, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1263-1263
Open Access | Times Cited: 71
Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies
Jean Bousquet, Jean‐Paul Cristol, Heather J. Zar, et al.
Clinical and Translational Allergy (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 70
Quercetin as a potential treatment for COVID-19-induced acute kidney injury: Based on network pharmacology and molecular docking study
Yue-Yu Gu, Min Zhang, Huan Cen, et al.
PLoS ONE (2021) Vol. 16, Iss. 1, pp. e0245209-e0245209
Open Access | Times Cited: 68
Discovery of naturally occurring inhibitors against SARS-CoV-2 3CLpro from Ginkgo biloba leaves via large-scale screening
Yuan Xiong, Guanghao Zhu, Haonan Wang, et al.
Fitoterapia (2021) Vol. 152, pp. 104909-104909
Open Access | Times Cited: 66
Effectiveness of Natural Antioxidants against SARS-CoV-2? Insights from the In-Silico World
Muhammad Fayyaz ur Rehman, Shahzaib Akhter, Aima Iram Batool, et al.
Antibiotics (2021) Vol. 10, Iss. 8, pp. 1011-1011
Open Access | Times Cited: 64
Flavonoids as Promising Antiviral Agents against SARS-CoV-2 Infection: A Mechanistic Review
Mohammad Amin Khazeei Tabari, Amin Iranpanah, Roodabeh Bahramsoltani, et al.
Molecules (2021) Vol. 26, Iss. 13, pp. 3900-3900
Open Access | Times Cited: 61
Nanotechnology as a Key to Enhance the Benefits and Improve the Bioavailability of Flavonoids in the Food Industry
Jocelyn C. Ayala-Fuentes, Rocío Alejandra Chávez-Santoscoy
Foods (2021) Vol. 10, Iss. 11, pp. 2701-2701
Open Access | Times Cited: 60
Quercetin: A Molecule of Great Biochemical and Clinical Value and Its Beneficial Effect on Diabetes and Cancer
Aikaterini-Spyridoula Michala, Agathi Pritsa
Diseases (2022) Vol. 10, Iss. 3, pp. 37-37
Open Access | Times Cited: 60
In vitro efficacy of Artemisia extracts against SARS-CoV-2
Chuanxiong Nie, Jakob Trimpert, Sooyeon Moon, et al.
Virology Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 57
The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications
Douglas B. Kell, Etheresia Pretorius
Biochemical Journal (2022) Vol. 479, Iss. 16, pp. 1653-1708
Open Access | Times Cited: 51
Discovery of METTL3 Small Molecule Inhibitors by Virtual Screening of Natural Products
Yue Du, Yongliang Yuan, Le Xu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 50
Page 1 - Next Page

Scroll to top